Completed

Phase 2
Age: 25Years - 49Years
All Genders
NCT00000501

Hypertension Prevention Trial (HPT) Feasibility Study

Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2013-11-26

N/A

Participants Needed

N/A

Research Sites

256 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

To test the feasibility and the efficacy of nutritional interventions in the primary prevention of hypertension in individuals predisposed to the development of hypertension; specifically, to test the hypothesis that reduction of weight and/or decreased sodium intake in obese individuals, or decreased sodium intake with or without increased potassium intake (in men and women, regardless of weight) would prevent the elevation of blood pressure and the incidence of hypertension.

CONDITIONS

Official Title

Hypertension Prevention Trial (HPT) Feasibility Study

Who Can Participate

Age: 25Years - 49Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

Men and women, ages 25 to 49. Diastolic blood pressure between 78 and 89 mm Hg. Free of major disease. Not on a special diet or antihypertensive medication at entry. Some mild to moderately obese subjects.

Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

Trial Site Locations

Site Locations not provided

Location information for this trial is currently unavailable.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

N/A

Allocation

RANDOMIZED

Model

N/A

Primary Purpose

PREVENTION

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Hypertension Prevention Trial (HPT) Feasibility Study | DecenTrialz